ArmaGen Inc:製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C10888)
◆英語タイトル:ArmaGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10888
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥36,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥73,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥109,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
ArmaGen Inc (ArmaGen), formerly ArmaGen Technologies Inc is a clinical stage biotechnology company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include AGT-181, AGT-182, AGT-183, AGT-184, AGT-187, AGT-115, AGT-190, AGT-110 and AGT-160. Its products are used for the treatment of neurological symptoms of lysosomal storage diseases. ArmaGen’s products are also used to treat neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. The company’s technology platform solution targets recombinant proteins, and therapeutic monoclonal antibodies to the brain. ArmaGen is headquartered in Calabasas, California, the US.

ArmaGen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ArmaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ArmaGen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ArmaGen Technologies Raises US$17 Million In Series A Financing 10
Partnerships 12
ArmaGen Enters into Research Agreement with Rett Syndrome Research Trust 12
Licensing Agreements 13
Shire Enters into Licensing Agreement with ArmaGen for AGT-182 13
ArmaGen Inc – Key Competitors 14
ArmaGen Inc – Key Employees 15
ArmaGen Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Jan 19, 2017: ArmaGen Appoints Mathias Schmidt, Ph.D., as Chief Executive Officer 17
Product Approvals 18
Nov 30, 2017: ArmaGen’s AGT-181 Granted Fast Track Designation for the Treatment of Hurler Syndrome (MPS I) 18
Clinical Trials 19
Feb 08, 2018: ArmaGen’s AGT-181 Demonstrates Neurocognitive Benefit in Children with Severe MPS I 19
Feb 16, 2017: ArmaGen Reports Preliminary Evidence of Cognitive Improvement in Children with Hurler Syndrome (MPS I) Treated with AGT-181 21
Feb 07, 2017: ArmaGen Announces Oral Presentation of Preliminary Results from its Phase 2 Clinical Trial of AGT-181 in Patients with MPS 1 to be Presented at WORLDSymposium 2017 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
ArmaGen Inc, Pharmaceuticals & Healthcare, Key Facts 2
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ArmaGen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ArmaGen Inc, Deals By Therapy Area, 2012 to YTD 2018 8
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ArmaGen Technologies Raises US$17 Million In Series A Financing 10
ArmaGen Enters into Research Agreement with Rett Syndrome Research Trust 12
Shire Enters into Licensing Agreement with ArmaGen for AGT-182 13
ArmaGen Inc, Key Competitors 14
ArmaGen Inc, Key Employees 15

List of Figures
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ArmaGen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ArmaGen Inc:製薬・医療:M&Aディール及び事業提携情報(ArmaGen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆